Company page
Alzamend Neuro, Inc.
Alzamend Neuro, Inc. is a public company traded under the ticker ALZN in the American market. The company has a market capitalization of approximately $4.64 million. Alzamend Neuro focuses on developing innovative therapies for neurological and psychiatric disorders.
- Ticker
- ALZN:NASDAQ
- Asset type
- Stock
- Market cap
- $4.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD